Clinical Trial Update: Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating repeated treatment with Wharton's Jelly-derived mesenchymal stromal cells in adults with Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Wharton’s jelly-derived mesenchymal stromal cells (Wharton’s jelly-derived mesenchymal stromal cells)

Snippet

Sponsor: NextCell Pharma Ab | Conditions: Type1diabetes | Phase 1, Phase 2 | Status: COMPLETED